GL1X · GenesisL1 explorer

Research workbench

Crystal structure of trk-a in complex with the pan-trk kinase inhibitor, compound 10E

Analyse Crystal structure of trk-a in complex with the pan-trk kinase inhibitor… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6J5L
Type
protein
Length
282 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
High affinity nerve growth factor receptor
EC
2.7.10.1
UniProt
P04629
Ligands
B9C
Pockets
1 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHigh affinity nerve growth factor receptor (EC 2.7.10.1)protein28238% helix, 17% strandP04629

Ligands and binding sites

  • B9C · N-{2-[({3-[6-(piperazin-1-yl)pyridin-3-yl]-1H-indazol-5-yl}amino)methyl]phenyl}methanesulfonamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13990.640.7846B9C

Compared structures

  • 6J5L · Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 10e · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.